|
"song yc"的相关文件
显示项目 1-16 / 16 (共1页)
1
每页显示[10|25|50]项目
| 國家衛生研究院 |
2023-03-31 |
Humoral and cellular immunity in three different types of COVID-19 vaccines against SARS-CoV-2 variants in a real-world data analysis
|
Song, YC;Liu, SJ;Lee, HJ;Liao, HC;Liu, CT;Wu, MY;Yen, HR |
| 中山醫學大學 |
2021 |
CHPF promotes malignancy of breast cancer cells by modifying syndecan-4 and the tumor microenvironment
|
Liao, WC; Yen, HR; Chen, CH; Chu, YH; Song, YC; Tseng, TJ; Liu, CH |
| 臺大學術典藏 |
2018-09-10T04:46:19Z |
Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death
|
Yeh, P.Y.;Chuang, S.-E.;Yeh, K.-H.;Song, Y.C.;Chang, L.L.-Y.;Cheng, A.-L.Yeh, Py;Chuang, Se;Kun-Huei, Yeh;Song, Yc;Chang, Ll;Cheng, Al.; KUN-HUEI YEH; Yeh, PY; Chuang, SE; ANN-LII CHENG; Kun-Huei, Yeh; Song, YC; Chang, LL; Cheng, AL. |
| 國家衛生研究院 |
2015-07-28 |
A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms
|
Song, YC;Liu, SJ |
| 國家衛生研究院 |
2014-11 |
Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a toll-like receptor agonist-conjugated peptide
|
Shen, KY;Song, YC;Chen, IH;Chong, P;Liu, SJ |
| 國家衛生研究院 |
2014-05 |
Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells
|
Shen, KY;Song, YC;Chen, IH;Leng, CH;Chen, HW;Li, HJ;Chong, P;Liu, SJ |
| 國家衛生研究院 |
2014-03 |
A purified recombinant lipopeptide as adjuvant for cancer immunotherapy
|
Song, YC;Liu, HH;Chen, IH;Chen, HW;Chong, P;Leng, CH;Liu, SJ |
| 國家衛生研究院 |
2014-01 |
A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity
|
Song, YC;Cheng, HY;Leng, CH;Chiang, SK;Lin, CW;Chong, P;Huang, MH;Liu, SJ |
| 國家衛生研究院 |
2011-08 |
Presentation of lipopeptide by dendritic cells induces anti-tumor responses via an endocytosis-independent pathway in vivo
|
Song, YC;Chou, AH;Homhuan, A;Huang, MH;Chiang, SK;Shen, KY;Chuang, PW;Leng, CH;Tao, MH;Chong, P;Liu, SJ |
| 國家衛生研究院 |
2004-06-18 |
Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappa B activation by protein phosphatase 4-mediated NF-kappa B p65 Thr dephosphorylation
|
Yeh, PY; Yeh, KH; Chuang, SE; Song, YC; Cheng, AL |
| 國立臺灣大學 |
2004-06 |
Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr-dephosphorylation.
|
Yeh, PY; Kun-Huei, Yeh; Chuang, SE; Song, YC; Cheng, AL. |
| 國家衛生研究院 |
2004-04-29 |
Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death
|
Yeh, PY; Chuang, SE; Yeh, KH; Song, YC; Chang, LLY; Cheng, AL |
| 國立臺灣大學 |
2004-04 |
Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death.
|
Yeh, PY; Chuang, SE; Kun-Huei, Yeh; Song, YC; Chang, LL; Cheng, AL. |
| 國家衛生研究院 |
2003-07-01 |
Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells
|
Yeh, PY; Chuang, SE; Yeh, KH; Song, YC; Cheng, AL |
| 國家衛生研究院 |
2002-04-15 |
Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation
|
Yeh, PY; Chuang, SE; Yeh, KH; Song, YC; Ea, CK; Cheng, AL |
| 國家衛生研究院 |
2001-06-22 |
Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin
|
Yeh, PY; Chuang, SE; Yeh, KH; Song, YC; Cheng, AL |
显示项目 1-16 / 16 (共1页)
1
每页显示[10|25|50]项目
|
